Company intelligence / Profile preview

Schiapparelli

Ownership
Private
Development stage
Other
01

Overview

Schiapparelli was a long-standing provider of automated centrifugal analysis instruments and diagnostic kits for clinical laboratories. It developed notable products such as the KII Ultracentrifuge, used in virus isolation for vaccine production, and a range of chemistry analyzers. The company exited the diagnostics business in the late 1990s after being acquired by Alfa Wassermann.

Therapeutic areas
Infectious DiseasesOther
Modalities
DeviceDiagnostic kit
Industry
Metabolite Diagnostics

Beyond the preview

Go deeper on Schiapparelli.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schiapparelli.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call